Ultrasound-Guided Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar Disc Herniation: A Prospective, Randomized, Controlled Study
Table 3
Longitudinal outcomes of life quality and nerve function for the PRP group over time.
Outcome
Time
PRP group ()
value#
PF of SF-36 (median (1st-3rd))
Baseline
60.0 (45.0-70.0)
Ref
1 week
75.0 (60.0-90.0)
0.284
1 month
88.0 (76.5-95.0)
<0.001
3 months
90.0 (82.5-95.0)
<0.001
6 months
90.0 (87.5-93.0)
<0.001
1 year
90.0 (90.0-95.0)
<0.001
value over time↑
<0.001
BP of SF-36 (median (1st-3rd))
Baseline
41.0 (31.0-51.0)
Ref
1 week
43.0 (41.0-52.0)
0.794
1 month
52.0 (41.0-62.0)
0.005
3 months
82.0 (61.0-94.0)
<0.001
6 months
74.0 (62.0-85.5)
<0.001
1 year
74.0 (64.0-87.0)
<0.001
value over time↑
<0.001
F-wave rate (%, median (1st-3rd))
Baseline
82.0 (80.0-85.0)
Ref
1 year
95.0 (92.0-100.0)
<0.001
F-wave latency (ms, median (1st-3rd))
Baseline
48.7 (46.9-49.7)
Ref
1 year
45.2 (44.5-46.2)
<0.001
PRP: platelet-rich plasma; 1st-3rd: 1st-3rd quartiles; SF-36: the 36-item short form health survey; PF: physical function; BP: bodily pain. # value compares difference from baseline using post hoc test or Wilcoxon signed-rank test. ↑ value indicates significance of overall change over time using the Friedman test.
